Evidence map›Paper›PMID 24367410›Full record

ReviewBeilstein journal of organic chemistry2013

Biosynthesis of rare hexoses using microorganisms and related enzymes.

Zijie Li, Yahui Gao, Hideki Nakanishi, Xiaodong Gao, Li Cai

Abstract readReview
In one paragraph

Review in Beilstein journal of organic chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. The Differential Growth Inhibition ofFrontiers in microbiology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. A two-step strategy for the preparation of 6-deoxy-l-sorbose.Bioorganic & medicinal chemistry letters · 2016
    Article
  12. Review
  13. Article
  14. Facile Enzymatic Synthesis of Ketoses.Angewandte Chemie (International ed. in English) · 2015
    Article
  15. Curious Cases of the Enzymes.Journal of medical biochemistry · 2015
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zijie LiThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.
Yahui GaoSchool of Food Science and Technology, Jiangnan University, Wuxi, 214122, China.
Hideki NakanishiThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.
Xiaodong GaoThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.
Li CaiDivision of Mathematics and Science, University of South Carolina Salkehatchie, Walterboro, South Carolina, 29488, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare sugars, referred to as monosaccharides and their derivatives that rarely exist in nature, can be applied in many areas ranging from foodstuffs to pharmaceutical and nutrition industry, or as starting materials for various natural products and drug candidates. Unfortunately, an important factor restricting the utilization of rare sugars is their limited availability, resulting from limited synthetic methods. Nowadays, microbial and enzymatic transformations have become a very powerful tool in this field. This article reviews the biosynthesis and enzymatic production of rare ketohexoses, aldohexoses and sugar alcohols (hexitols), including D-tagatose, D-psicose, D-sorbose, L-tagatose, L-fructose, 1-deoxy-L-fructose, D-allose, L-glucose, L-talose, D-gulose, L-galactose, L-fucose, allitol, D-talitol, and L-sorbitol. New systems and robust catalysts resulting from advancements in genomics and bioengineering are also discussed.

Indexed as

biosynthesisenzymehexosemicroorganismrare sugars

Identifiers

PMID24367410
PMCPMC3869271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.